|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.10 CNY | +1.42% |
|
-9.23% | -35.88% |
Company Valuation: Chongqing Zhifei Biological Products Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,99,360 | 1,40,528 | 1,46,664 | 62,957 | 45,171 | 28,965 | - | - |
| Change | - | -29.51% | 4.37% | -57.07% | -28.25% | -35.88% | - | - |
| Enterprise Value (EV) 1 | 1,95,858 | 1,39,911 | 1,43,334 | 72,599 | 54,823 | 37,630 | 36,746 | 35,550 |
| Change | - | -28.56% | 2.45% | -49.35% | -24.49% | -31.36% | -2.35% | -3.25% |
| P/E ratio | 19.6x | 18.6x | 18.2x | 31.2x | -3.07x | -18.7x | -66.9x | 146x |
| PBR | 11.3x | 5.8x | 4.66x | 2.04x | 2.85x | 1.96x | 2.05x | 2.04x |
| PEG | - | -0.7x | 2.59x | -0.4x | 0x | 0.2x | 0.9x | -1x |
| Capitalization / Revenue | 6.51x | 3.67x | 2.77x | 2.41x | 5.04x | 3.45x | 3.22x | 2.92x |
| EV / Revenue | 6.39x | 3.66x | 2.71x | 2.78x | 6.12x | 4.48x | 4.09x | 3.58x |
| EV / EBITDA | 15.8x | 15.4x | 14.8x | 27.3x | - | -129x | 63.3x | 33.8x |
| EV / EBIT | 16.3x | 16x | 15.3x | 32.1x | - | -67.8x | 47.1x | 37.8x |
| EV / FCF | 29.8x | 261x | 17.8x | -13.6x | 12x | 7.02x | - | - |
| FCF Yield | 3.36% | 0.38% | 5.6% | -7.35% | 8.31% | 14.3% | - | - |
| Dividend per Share 2 | 0.4 | 0.3333 | 0.8 | 0.2 | - | - | 0.0133 | 0.05 |
| Rate of return | 0.48% | 0.57% | 1.31% | 0.76% | - | - | 0.11% | 0.41% |
| EPS 2 | 4.249 | 3.141 | 3.362 | 0.8427 | -6.151 | -0.6466 | -0.1807 | 0.0831 |
| Distribution rate | 9.41% | 10.6% | 23.8% | 23.7% | - | - | -7.38% | 60.2% |
| Net sales 1 | 30,637 | 38,264 | 52,918 | 26,070 | 8,958 | 8,406 | 8,982 | 9,927 |
| EBITDA 1 | 12,394 | 9,079 | 9,700 | 2,656 | - | -291.6 | 580.9 | 1,051 |
| EBIT 1 | 11,986 | 8,758 | 9,373 | 2,264 | - | -555 | 780.5 | 941.2 |
| Net income 1 | 10,197 | 7,539 | 8,070 | 2,018 | -14,723 | -1,550 | -433.1 | 202.3 |
| Net Debt 1 | -3,502 | -616.7 | -3,330 | 9,643 | 9,652 | 8,665 | 7,781 | 6,585 |
| Reference price 2 | 83.07 | 58.55 | 61.11 | 26.30 | 18.87 | 12.10 | 12.10 | 12.10 |
| Nbr of stocks (in thousands) | 24,00,000 | 24,00,000 | 24,00,000 | 23,93,790 | 23,93,790 | 23,93,790 | - | - |
| Announcement Date | 08/02/22 | 20/03/23 | 22/04/24 | 21/04/25 | 27/04/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -18.45x | 4.43x | -127.66x | -.--% | 421.57Cr | ||
| 15.83x | 3.42x | 9.22x | 0.64% | 6.22TCr | ||
| 28.14x | 5.7x | 16.49x | 0.56% | 5.74TCr | ||
| 30.73x | 10.37x | 19.57x | -.--% | 3.7TCr | ||
| -42.03x | 2.74x | 8.09x | 4.12% | 3.36TCr | ||
| 31.1x | 3.39x | 10.24x | -.--% | 2.84TCr | ||
| 15.33x | 2.69x | 8.31x | -.--% | 2.01TCr | ||
| -5.51x | 7.34x | -4.48x | -.--% | 1.89TCr | ||
| 24.85x | 5.14x | 13.86x | -.--% | 1.63TCr | ||
| 47.09x | 4.97x | 35.71x | -.--% | 1.63TCr | ||
| Average | 12.71x | 5.02x | -1.06x | 0.53% | 2.94TCr | |
| Weighted average by Cap. | 15.30x | 5.06x | 10.72x | 0.72% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 300122 Stock
- Valuation Chongqing Zhifei Biological Products Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















